Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		22 Months Ended	166 Months Ended
	Jun. 30, 2011 Successor	Jun. 30, 2010 Successor	Jun. 30, 2011 Successor	Aug. 31, 2009 Predecessor	Aug. 31, 2009 Predecessor Series A Preferred Stock	Aug. 31, 2009 Predecessor Series B Preferred Stock	Aug. 31, 2009 Predecessor Series D Preferred Stock [Member]
Cash flows from operating activities:
Net loss	$ (27,210,462)	$ (6,459,340)	$ (45,191,992)	$ (115,322,121)
Adjustments to reconcile net loss to net cash used in operating activities:
Reorganization items, net	0	0	72,477	(74,648,976)
Expense related to equity awards and issuance of stock	2,402,730	633,985	4,276,489	10,608,999
Warrant expense (income)	9,806,882	(295,186)	10,591,198	0
Derivative revaluation (expense)	(8,182,138)	0	(8,182,138)	0
Uncompensated contribution of services	0	0	0	755,556
Depreciation and amortization	12,590	3,140	20,675	9,091,990
Provision for doubtful accounts	(12,280)	(15,791)	(66,717)	337,810
Provision for excessive and/or obsolete inventory	5,178	(13,857)	(43,524)	259,427
Amortization of debt issue costs	0	0	0	4,107,067
Amortization of debt discounts on investments	0	0	0	(508,983)
Loss on disposal or impairment of property and equipment	0	0	0	17,668,477
Foreign exchange loss (gain) on substantial liquidation of foreign entity	(4,988)	4,333	(12,674)	(2,256,408)
Net (loss) income attributable to noncontrolling interest	46,552	16,388	113,943	(1,799,523)
Change in operating assets and liabilities, excluding effects of acquisition:
Decrease (increase) in accounts receivable	3,626	6,512	74,856	(91,496)
Decrease (increase) in other receivables	485	(96)	1,192	218,978
Decrease (increase) in inventory	(12,931)	6,111	45,451	(455,282)
Decrease in prepaid expenses	201,058	198,762	(1,048)	34,341
Decrease in other assets	0	0	4,120	71,000
Increase (decrease) in accounts payable	(325,914)	535,134	632,810	57,648
Increase in accrued expenses, liabilities subject to compromise and other liabilities	301,757	1,004,250	1,132,103	3,311,552
Decrease in deferred revenue	0		0	(50,096)
Net cash used in operating activities	(6,603,579)	(4,375,655)	(20,168,503)	(148,610,040)
Cash flows from investing activities:
Acquisition of Agera, net of cash acquired	0	0	0	(2,016,520)
Purchase of property and equipment	(700,513)	(29,675)	(730,187)	(25,515,170)
Proceeds from the sale of property and equipment, net of selling costs	0	0	0	6,542,434
Purchase of investments	0	0	0	(152,998,313)
Proceeds from sales and maturities of investments	0	0	0	153,507,000
Net cash used in investing activities	(700,513)	(29,675)	(730,187)	(20,480,569)
Cash flows from financing activities:
Proceeds from convertible debt	0	0	0	91,450,000
Offering costs associated with the issuance of convertible debt	0	0	0	(3,746,193)
Proceeds from notes payable to shareholders, net	0	0	0	135,667
Proceeds from the issuance of redeemable preferred stock net					12,931,800	0	0
Proceeds from exercise of warrants		0	1,973,364	0
Proceeds from the issuance of common stock, net	1,580,560	3,469,400	6,849,960	93,753,857
Costs associated with secured loan and debtor-in-possession loan	0	0	0	(360,872)
Proceeds from secured loan	0	0	0	500,471
Proceeds from debtor-in-possession loan	0	0	0	2,750,000
Payments on insurance loan	(48,655)	(40,861)	(134,229)	(79,319)
Cash dividends paid on preferred stock	(304,384)	(91,000)	(444,134)	(1,087,200)
Cash paid for fractional shares of preferred stock	0	0	0	(38,108)
Merger and acquisition expenses	0	0	0	(48,547)
Repurchase of common stock	0	0	0	(26,024,280)
Net cash provided by financing activities	9,036,865	3,337,539	22,479,911	170,137,276
Effect of exchange rate changes on cash balances	5,870	(4,662)	14,884	(36,391)
Net increase (decrease) in cash and cash equivalents	1,738,643	(1,072,453)	1,596,105	1,010,276
Cash and cash equivalents, beginning of period	867,738	1,362,488	1,010,276
Cash and cash equivalents, end of period	2,606,381	290,035	2,606,381	1,010,276
Supplemental disclosures of cash flow information:
Predecessor cash paid for interest	0	0	0	12,715,283
Successor cash paid for dividends	304,384	91,000	444,134	0
Non-cash investing and financing activities:
Predecessor deemed dividend associated with beneficial conversion of preferred stock	0	0	0	(11,423,824)
Predecessor preferred stock dividend	0	0	0	1,589,861
Successor accrued preferred stock dividend	366,135	97,011	366,135	0
Predecessor uncompensated contribution of services	0	0	0	755,556
Predecessor common stock issued for intangible assets	0	0	0	540,000
Predecessor common stock issued in connection with conversion of debt	0	0	0	10,814,000
Predecessor equipment acquired through capital lease	0	0	0	167,154
Successor/Predecessor financing of insurance premiums	0	0	178,582	87,623
Successor issuance of notes payable	0	0	0	6,000,060
Successor common stock issued in connection with reorganization	0	0	0	5,472,000
Successor intangible assets	0	0	0	6,340,656
Successor deferred tax liability in connection with fresh-start	0	0	0	2,500,000
Elimination of Predecessor common stock and fresh start adjustment	0	0	0	14,780,320
Successor accrued warrant liability	4,994,307	2,890,711	12,381,509	0
Successor conversion of preferred stock Series A balance and derivative balance into common stock	4,072,053	0	4,436,053	0	0
Successor exercise of warrants-cashless	341,424	0	341,424	0
Successor accrued derivative liability	$ 372,495	$ 0	$ 2,492,855	$ 0